Medication Therapy Management: Improving Health Outcomes and Reducing Cost

Why the Medication Therapy Management (MTM) Program Matters

At Navitus, we know that patients with chronic diseases can face greater risks for medication-related challenges such as non-adherence. This can lead to poor health outcomes and higher plan costs. That’s why we developed an MTM program, offered through our Clinical Engagement Center (CEC), that’s tailored to your plan-specific needs, enabling patients with chronic diseases to achieve optimal therapy outcomes.

Our customizable, fully CMS-compliant MTM program is built to support Medicare Part D, with the additional ability to support Medicaid and Commercial plans looking to improve patient health outcomes. This program can also help you boost your Star Ratings and achieve savings.

Meeting Your Needs with Tailored Programs

Whether you’re looking for full-service, hybrid or Software as a Service (SaaS), our MTM program delivers the high-touch, collaborative MTM partnership you’re seeking with targeted patient interventions using customizable and automated clinical algorithms, direct prescriber engagement with evidence-based recommendations and opportunities for pharmacy outreach.

Expertise to Put Goals Within Reach

Program Recommendations Tailored to You

Targeted Medication Review Criteria Specific to Your Plan

Expertise in Numerous Plan Types Including MA-PD, PDP, Commercial & more

Guaranteed CMR Rate Chosen by You

A Seamless Process

  • Plan design that fits program criteria and target requirements
  • 24/7 reporting options to meet, or exceed, your needs
  • Dedicated CEC clinical staff with comprehensive access to patient data

Operational Excellence

  • Real-time access to MTM reporting
  • Cross-functional support to monitor CMS requirements
  • Auditing rights covering any and all components of the program at any time
  • Unlimited number of users

What Makes Us Different

  • Customization
  • Hands on account support
  • Direct access to MTM account team
  • Regular performance meetings
  • Compliance and auditing beyond the industry standard

Help Your Patients Take Control of Their Medication Management

Email us at [email protected] to learn more.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

previous arrow
next arrow